• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    LFW Photonics Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Penumbra, Inc. Common Stock (NY:PEN)

    317.42 +1.88 (+0.59%)
    Streaming Delayed Price Updated: 11:08 AM EST, Jan 9, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Press Releases about Penumbra, Inc. Common Stock

    Penumbra Inc. (NYSE: PEN) Leading the Way in Monday Trading Based on Percentage Gain
    Via Investor Brand Network
    Penumbra Inc. (NYSE: PEN) Highlighted for Surprising Price Action
    Via Investor Brand Network
    Penumbra Inc. (NYSE: PEN) is a Stock Spotlight on 7/5
    Via Investor Brand Network
    Penumbra Inc. (NYSE: PEN) is a Stock Spotlight on 5/30
    Via Investor Brand Network
    Penumbra Inc. (NYSE: PEN) is a Stock Spotlight on 5/12
    Via Investor Brand Network
    Penumbra Inc. (NYSE: PEN) is a Stock Spotlight on 5/4
    Via Investor Brand Network
    News headline image
    Are These Medical Device Makers Getting Ready To Rally?
    Current trends and changing demographics are behind growth of medical technology companies. An aging population and a shift to in-home care are among factors. 
    Via MarketBeat
    News headline image
    Penumbra Launches First Hands-Free, Full Body Virtual Reality-Based Offering for Rehabilitation, Expanding REAL® System Platform
    From Penumbra, Inc.
    Via Business Wire
    News headline image
    Penumbra and Asahi Intecc Partner With Goal of Introducing Indigo™ System Including Lightning™ Intelligent Aspiration to Japan
    From Penumbra, Inc.
    Via Business Wire
    News headline image
    Penumbra Announces European Launch of RED® Reperfusion Catheters for Stroke Care
    From Penumbra, Inc.
    Via Business Wire
    News headline image
    Latest Data Demonstrates Penumbra System and RED® Reperfusion Catheters Effective for Broad Stroke Care
    From Penumbra, Inc.
    Via Business Wire
    News headline image
    Penumbra Announces the European Launch of the Indigo® System With Lightning™ 7 and Lightning 12 Intelligent Aspiration
    From Penumbra, Inc.
    Via Business Wire
    News headline image
    Penumbra Introduces Next Generation REAL® y-Series™, Expanding Virtual Reality Healthcare Platform
    From Penumbra, Inc
    Via Business Wire
    News headline image
    New Data Demonstrates Safety and Performance of Continuous Aspiration Thrombectomy with Penumbra’s Indigo® System CAT™ RX Catheter in High-Risk Patients with Acute Coronary Syndrome
    From Penumbra, Inc.
    Via Business Wire
    News headline image
    EQUITY ALERT: ROSEN, A TOP RANKED LAW FIRM, Encourages Penumbra, Inc. Investors With Losses to Inquire About Class Action Investigation – PEN
    From The Rosen Law Firm, P.A.
    Via Business Wire
    News headline image
    Penumbra Introduces REAL® i-Series™, Expanding REAL Immersive System to Support Broad Range of Care Providers and Mental Health Professionals
    From Penumbra, Inc.
    Via Business Wire
    News headline image
    Penumbra Receives FDA Clearance for RED 62 Reperfusion Catheter, Enabling Physicians to Address Broad Range of Stroke Patients
    From Penumbra, Inc.
    Via Business Wire
    News headline image
    NYSE: PEN Long Term Investor Notice: Investigation of Potential Wrongdoing at Penumbra, Inc. ↗
    San Diego, CA -- (SBWIRE) -- 05/10/2021 -- An investigation on behalf of current long term investors in Penumbra, Inc. (NYSE: PEN) shares over possible breaches of fiduciary duty by certain officers... 
    Via SBWire
    Topics Death Lawsuit
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.